140 related articles for article (PubMed ID: 9630838)
1. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 reduces natural killer (NK) sensitivity of tumor cells by downregulating NK target structure expression.
Tsuruma T; Yagihashi A; Hirata K; Torigoe T; Araya J; Watanabe N; Sato N
Cell Immunol; 1999 Dec; 198(2):103-10. PubMed ID: 10648124
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.
Kundu N; Fulton AM
Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639
[TBL] [Abstract][Full Text] [Related]
4. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression.
Salazar-Onfray F; Petersson M; Franksson L; Matsuda M; Blankenstein T; Kärre K; Kiessling R
J Immunol; 1995 Jun; 154(12):6291-8. PubMed ID: 7759867
[TBL] [Abstract][Full Text] [Related]
5. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
7. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
Ma D; Luyten GP; Luider TM; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
[TBL] [Abstract][Full Text] [Related]
8. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells play a role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Kijima M; Saio M; Oyang GF; Suwa T; Miyauchi R; Kojima Y; Imai H; Nakagawa J; Nonaka K; Umemura N; Nishimura T; Takami T
Int J Oncol; 2005 Mar; 26(3):679-84. PubMed ID: 15703823
[TBL] [Abstract][Full Text] [Related]
10. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
11. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
12. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
[TBL] [Abstract][Full Text] [Related]
14. Natural killer target molecules associated with the transformation of the oncogene-transfected fibroblast.
Cho JM; Sato N; Yagihashi A; Konno A; Hara I; Konn S; Torigoe T; Qi W; Takashima T; Takahashi N
Cancer Res; 1991 Aug; 51(16):4250-6. PubMed ID: 1868445
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 inhibited the expression of tumor antigens and major histocompatibility complex antigen on EJ-ras oncogene transformants.
Tsuruma T; Yagihashi A; Torigoe T; Okada Y; Sato N; Kikuchi K; Hirata K
Artif Organs; 1996 Aug; 20(8):895-7. PubMed ID: 8853802
[TBL] [Abstract][Full Text] [Related]
16. Involvement of peptide antigens in the cytotoxicity between 70-kDa heat shock cognate protein-like molecule and CD3+, CD4-, CD8-, TCR-alpha beta- killer T cells.
Takashima S; Sato N; Kishi A; Tamura Y; Hirai I; Torigoe T; Yagihashi A; Takahashi S; Sagae S; Kudo R; Kikuchi K
J Immunol; 1996 Oct; 157(8):3391-5. PubMed ID: 8871636
[TBL] [Abstract][Full Text] [Related]
17. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
[TBL] [Abstract][Full Text] [Related]
18. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
19. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
Talmadge JE; Phillips H; Schindler J; Tribble H; Pennington R
Cancer Res; 1987 Nov; 47(21):5725-32. PubMed ID: 3499218
[TBL] [Abstract][Full Text] [Related]
20. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]